Concepedia

Author

Satoru Ito

Taiho Pharmaceutical (Japan)ORCID

Also Known As

Ito, Satoru, S. ITO, Satoru Ito

22

Publications

418

Citations

9

H-Index

13

Concepts

All Affiliations

Taiho Pharmaceutical (Japan)Mitsui Sugar (Japan)University of the RyukyusOkinawa Prefectural Agricultural Research Center
SI

About

Satoru Ito is an author at Taiho Pharmaceutical (Japan) specializing in health sciences, food chemistry, and food processing.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Health Sciences

2

2

119

2

Engineering

1

1

17

3

Allergy

1

1

15

4

Biochemistry

1

1

17

5

Biomolecular Engineering

1

1

17

Satoru Ito

×

8

Publications

387

Citations

8

H-Index

YearCitations

Futibatinib Is a Novel Irreversible FGFR 1–4 Inhibitor That Shows Selective Antitumor Activity against FGFR-Deregulated Tumors

Hiroshi Sootome, Hidenori Fujita, Kenjiro Ito,

Cancer Research

2020

184

Effects of different drying–solidification processes on physical properties, volatile fraction, and antioxidant activity of non-centrifugal cane brown sugar

Yonathan Asikin, Naoto Hirose, Hajime Tamaki,

LWT

2015

84

Compositional and Electronic Discrimination Analyses of Taste and Aroma Profiles of Non-Centrifugal Cane Brown Sugars

Yonathan Asikin, Wakana Takahara, Makoto Takahashi,

Food Analytical Methods

2016

35

Discovery of Futibatinib: The First Covalent FGFR Kinase Inhibitor in Clinical Use

Satoru Ito, Sachie Otsuki, Hirokazu Ohsawa,

ACS Medicinal Chemistry Letters

2023

31

Enantioselectivity in the reduction of α-dicarvelone by cell suspension cultures of Nicotiana tabacum

Hiroki Hamada, Narihiro Nakamura, Satoru Ito,

Phytochemistry

1988

17

New triterpenoid saponins from cacti and anti-type I allergy activity of saponins from cactus

Kazutaka Kakuta, Masaki Baba, Satoru Ito,

Bioorganic & Medicinal Chemistry Letters

2012

15

TAS-121, A Selective Mutant EGFR Inhibitor, Shows Activity Against Tumors Expressing Various <i>EGFR</i> Mutations Including T790M and Uncommon Mutations G719X

Kimihiro Ito, Makoto Nishio, Masanori Kato,

Molecular Cancer Therapeutics

2019

11

Fragment-Based Discovery of Allosteric Inhibitors of SH2 Domain-Containing Protein Tyrosine Phosphatase-2 (SHP2)

James E. H. Day, Valério Berdini, Joan Castro,

Journal of Medicinal Chemistry

2024

10

Page 1